Traditional Chinese medicine during the COVID-19 pandemic: recent successes and future perspectives

Conflict of interest statement

Mei Wang is editorial board members of this journal. None of the other authors declare any conflicts of interest.

Funding

This study was supported by the Haihe Laboratory of Modern Chinese Medicine (22HHZYSS00001).

Author contributions

Mei Wang and Xiaopeng Chen conceived the idea for this study, Xiaopeng Chen drafted the manuscript, and Mei Wang and Xiaopeng Chen modified the manuscript.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgments

None.

Data availability

All data used to support the findings of this study have been included in this article.

References

[1] Xiao GX, Wang SM, Wang RJ, et al.“Three medicines and three formulas” in COVID-19: from bench to bedside. Acupunct Herb Med. 2023. doi:10.1097/HM9.0000000000000082.

[2] He QY, Shi YM, Tang Q, et al.Herbal medicine in the treatment of COVID-19 based on the gut-lung axis. Acupunct Herb Med. 2022;2(3):172-183.

[3] Vincent F, Nueda A, Lee J, et al.Phenotypic drug discovery: recent successes, lessons learned and new directions. Nat Rev Drug Discov. 2022;21(12):899-914.

RIGHTS & PERMISSIONS

Acupuncture and Herbal Medicine